KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $211,000 | -42.0% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $364,000 | +2.5% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $355,000 | -35.1% | 36,200 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $547,000 | +6.2% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $515,000 | +219.9% | 36,200 | +120.7% | 0.00% | +100.0% |
| Q3 2019 | $161,000 | -19.9% | 16,400 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $201,000 | -52.0% | 32,800 | +65.7% | 0.00% | -50.0% |
| Q1 2019 | $419,000 | +175.7% | 19,800 | +20.7% | 0.00% | +100.0% |
| Q4 2018 | $152,000 | -63.7% | 16,400 | -17.2% | 0.00% | -50.0% |
| Q3 2018 | $419,000 | +21.8% | 19,800 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $344,000 | +27.9% | 20,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $269,000 | +100.7% | 20,300 | +31.0% | 0.00% | 0.0% |
| Q1 2016 | $134,000 | -44.9% | 15,500 | -14.8% | 0.00% | -33.3% |
| Q4 2015 | $243,000 | +27.9% | 18,200 | +1.1% | 0.00% | +50.0% |
| Q3 2015 | $190,000 | -59.7% | 18,000 | +4.0% | 0.00% | -66.7% |
| Q2 2015 | $471,000 | -7.8% | 17,300 | +3.6% | 0.01% | 0.0% |
| Q1 2015 | $511,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 999,275 | $37,403,000 | 55.08% |
| New Leaf Venture Partners, L.L.C. | 126,687 | $4,742,000 | 2.31% |
| Cormorant Asset Management, LP | 385,000 | $14,411,000 | 2.22% |
| SECTORAL ASSET MANAGEMENT INC | 529,920 | $19,835,000 | 0.89% |
| PFM Health Sciences, LP | 850,337 | $31,828,000 | 0.74% |
| Partner Investment Management, L.P. | 16,399 | $614,000 | 0.25% |
| Tekla Capital Management LLC | 137,766 | $5,157,000 | 0.24% |
| Candriam S.C.A. | 298,000 | $11,154,000 | 0.23% |
| Eventide Asset Management | 30,000 | $1,123,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 81,047 | $3,034,000 | 0.12% |